Reflect Scientific (RSCF) 10-Q 8 Aug 23 2023 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 04, 2023
Document Information Line Items
Entity Registrant Name	REFLECT SCIENTIFIC, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		85,214,086
Amendment Flag	false
Entity Central Index Key	0001103090
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-31377
Entity Incorporation, State or Country Code	UT
Entity Tax Identification Number	87-0642556
Entity Address, Address Line One	1266 South 1380 West
Entity Address, City or Town	Orem
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84058
City Area Code	(801)
Local Phone Number	226-4100
Title of 12(b) Security	None
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 1,408,758	$ 1,381,927
Accounts receivable, net	92,717	129,329
Inventories, net	877,086	797,352
Prepaid expenses and other current assets	23,924	20,221
Total Current Assets	2,402,485	2,328,829
Operating lease right-of-use assets	25,008	54,265
Goodwill	60,000	60,000
Other long-term assets	3,100	3,100
TOTAL ASSETS	2,490,593	2,446,194
Current Liabilities
Accounts payable and accrued expenses	43,571	78,969
Customer deposits	438,837	13,230
Current portion of operating lease liabilities	26,760	57,393
Total Current Liabilities	509,168	149,592
TOTAL LIABILITIES	509,168	149,592
Stockholders' Equity
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; none issued and outstanding as of June 30, 2023 and December 31, 2022
Common shares, $0.01 par value, 100,000,000 shares authorized; 85,214,086 shares issued and outstanding as of June 30, 2023 and December 31, 2022	852,140	852,140
Additional paid-in capital	20,265,931	20,252,181
Accumulated deficit	(19,136,646)	(18,807,719)
TOTAL STOCKHOLDERS’ EQUITY	1,981,425	2,296,602
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 2,490,593	$ 2,446,194

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	85,214,086	85,214,086
Common stock, shares outstanding	85,214,086	85,214,086

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenues	$ 124,384	$ 555,615	$ 365,511	$ 1,309,191
Cost of goods sold	63,850	195,821	177,483	430,110
Gross profit	60,534	359,794	188,028	879,081
Operating Expenses
Salaries and wages	154,569	159,565	316,844	329,844
General and administrative	81,361	103,775	188,353	220,953
Research and development	5,380	18,329	11,446	43,654
Total Operating Expenses	241,310	281,669	516,643	594,451
INCOME (LOSS) FROM OPERATIONS	(180,776)	78,125	(328,615)	284,630
NET INCOME (LOSS) BEFORE INCOME TAXES	(180,776)	78,125	(328,615)	284,630
INCOME TAX BENEFIT (EXPENSE)	(312)		(312)
NET INCOME (LOSS)	$ (181,088)	$ 78,125	$ (328,927)	$ 284,630
Earnings (loss) per common share
Basic (in Dollars per share)	$ 0	$ 0	$ 0	$ 0
Diluted (in Dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding
Basic (in Shares)	85,214,086	84,989,086	85,214,086	84,989,086
Diluted (in Shares)	85,214,086	85,739,086	85,214,086	85,739,086

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Shares	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 849,890	$ 20,226,931	$ (18,897,115)	$ 2,179,706
Balance (in Shares) at Dec. 31, 2021	84,989,086
Stock-based compensation		12,844		12,844
Net income (loss)			206,505	206,505
Balance at Mar. 31, 2022	$ 849,890	20,239,775	(18,690,610)	2,399,055
Balance (in Shares) at Mar. 31, 2022	84,989,086
Balance at Dec. 31, 2021	$ 849,890	20,226,931	(18,897,115)	2,179,706
Balance (in Shares) at Dec. 31, 2021	84,989,086
Net income (loss)				284,630
Balance at Jun. 30, 2022	$ 849,890	20,240,681	(18,612,485)	2,478,086
Balance (in Shares) at Jun. 30, 2022	84,989,086
Balance at Mar. 31, 2022	$ 849,890	20,239,775	(18,690,610)	2,399,055
Balance (in Shares) at Mar. 31, 2022	84,989,086
Stock-based compensation		906		906
Net income (loss)			78,125	78,125
Balance at Jun. 30, 2022	$ 849,890	20,240,681	(18,612,485)	2,478,086
Balance (in Shares) at Jun. 30, 2022	84,989,086
Balance at Dec. 31, 2022	$ 852,140	20,252,181	(18,807,719)	2,296,602
Balance (in Shares) at Dec. 31, 2022	85,214,086
Stock-based compensation		6,875		6,875
Net income (loss)			(147,839)	(147,839)
Balance at Mar. 31, 2023	$ 852,140	20,259,056	(18,955,558)	2,155,638
Balance (in Shares) at Mar. 31, 2023	85,214,086
Balance at Dec. 31, 2022	$ 852,140	20,252,181	(18,807,719)	2,296,602
Balance (in Shares) at Dec. 31, 2022	85,214,086
Net income (loss)				(328,927)
Balance at Jun. 30, 2023	$ 852,140	20,265,931	(19,136,646)	1,981,425
Balance (in Shares) at Jun. 30, 2023	85,214,086
Balance at Mar. 31, 2023	$ 852,140	20,259,056	(18,955,558)	2,155,638
Balance (in Shares) at Mar. 31, 2023	85,214,086
Stock-based compensation		6,875		6,875
Net income (loss)			(181,088)	(181,088)
Balance at Jun. 30, 2023	$ 852,140	$ 20,265,931	$ (19,136,646)	$ 1,981,425
Balance (in Shares) at Jun. 30, 2023	85,214,086

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (328,927)	$ 284,630
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation	13,750	13,750
Amortization of right-of-use assets	29,257	27,741
Changes in operating assets and liabilities:
Accounts receivable	36,612	(355,405)
Inventories	(79,734)	(238,669)
Prepaid expenses and other current assets	(3,703)	28,206
Accounts payable and accrued expenses	(35,398)	45,513
Customer deposits	425,607	(4,495)
Operating lease liabilities	(30,633)	(27,441)
Net cash provided by(used in) operating activities	26,831	(226,170)
CASH FLOWS FROM INVESTING ACTIVITIES
Net cash provided by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Net cash provided by financing activities
NET CHANGE IN CASH AND CASH EQUIVALENTS	26,831	(226,170)
CASH AND CASH EQUIVALENTS
Beginning of the period	1,381,927	1,473,924
End of the period	1,408,758	1,247,754
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest
Cash paid for income taxes

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Basis of Presentation [Abstract]
BASIS OF PRESENTATION	NOTE 1—BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Reflect Scientific, Inc. (the “Company,” “we,” “us,” or “our”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. They do not include all the information and footnotes required by GAAP for complete financial statements. December 31, 2022, consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2023
Recent Accounting Pronouncements [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 2—RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). The Company has evaluated all recent accounting pronouncements and determined that the adoption of pronouncements applicable to the Company has not had or is not expected to have a material impact on the Company's condensed consolidated financial statements.

Disaggregation of Revenues

Disaggregation of Revenues	6 Months Ended
	Jun. 30, 2023
Disaggregation of Revenues [Abstract]
DISAGGREGATION OF REVENUES	NOTE 3—DISAGGREGATION OF REVENUES Our revenue is disaggregated based on product category and geographical region. We recognize revenue from the sale of scientific equipment for the life sciences and manufacturing industries. Our products range from non-mechanical Cyrometrix freezers, chillers, and original equipment manufacturer (“OEM”) value-added products and components for the life sciences industry. The Company’s revenues for the three months ended June 30, 2023 and 2022 are disaggregated as follows: Three Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 10,508 $ - $ 10,508 OEM and other 81,155 32,721 113,876 Total Revenues $ 91,663 $ 32,721 $ 124,384 Three Months Ended June 30, 2022 United States International Total Revenues Freezers and chillers $ 309,704 $ - $ 309,704 OEM and other 195,604 50,307 245,911 Total Revenues $ 505,308 $ 50,307 $ 555,615 The Company’s revenues for the six months ended June 30, 2023 and 2022 are disaggregated as follows: Six Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 55,758 $ - $ 55,758 OEM and other 209,035 100,718 309,753 Total Revenues $ 264,793 $ 100,718 $ 365,511 Six Months Ended June 30, 2022 United States International Total Revenues Freezers and chillers $ 658,162 $ 153,236 $ 811,398 OEM and other 368,047 129,746 497,793 Total Revenues $ 1,026,209 $ 282,982 $ 1,309,191

Inventories

Inventories	6 Months Ended
	Jun. 30, 2023
Inventories [Abstract]
INVENTORIES	NOTE 4—INVENTORIES Inventories at June 30, 2023 and December 31, 2022 consisted of the following: June 30, December 31, Finished goods $ 365,842 $ 376,334 Raw materials 617,288 527,062 Total inventories 983,130 903,396 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 877,086 $ 797,352 Inventory balances are composed of finished goods and raw materials. Work in process inventory is immaterial to the condensed consolidated financial statements.

Leases

Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
LEASES	NOTE 5—LEASES The following was included in our condensed consolidated balance sheets at June 30, 2023 and December 31, 2022: June 30, December 31, Operating lease right-of-use assets $ 25,008 $ 54,265 Lease liabilities, current portion 26,760 57,393 Lease liabilities, long-term - - Total operating lease liabilities $ 26,760 $ 57,393 Weighted-average remaining lease term (months) 5 11 Weighted average discount rate 5.25% 5.25% Total lease expense for the three and six months ended June 30, 2023 and 2022 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating lease expense $ 15,216 $ 15,216 $ 30,432 $ 30,432 Variable lease expense 7,202 1,395 11,639 3,788 Total lease expense $ 22,418 $ 16,611 $ 42,071 $ 34,220 As of June 30, 2023, maturities of operating lease liabilities were as follows: Year Ending December 31, Amount 2023 – remaining $ 27,112 Less: imputed interest (352 ) Total operating lease liabilities $ 26,760

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2023
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 6—STOCKHOLDERS’ EQUITY Common Stock As of June 30, 2023, the Company was authorized to issue 100,000,000 common shares. As of June 30, 2023 and December 31, 2022, the Company had 85,214,086 common shares issued and outstanding. Restricted Stock Awards Below is a table summarizing the changes in restricted stock awards outstanding during the six months ended June 30, 2023: Restricted Stock Awards Weighted- Outstanding at December 31, 2022 450,000 $ 0.11 Granted - - Vested - - Forfeited - - Outstanding at June 30, 2023 450,000 $ 0.11 Stock-based compensation expense of $6,875 and $906 was recorded during the three months ended June 30, 2023 and 2022, respectively. Stock-based compensation expense of $13,750 was recorded during the six months ended June 30, 2023 and 2022, respectively. As of June 30, 2023, the remaining unrecognized stock-based compensation expense related to non-vested restricted stock awards is $41,250 and is expected to be recognized over 1.5 years.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2023
Earnings (Loss) Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	NOTE 7—EARNINGS (LOSS) PER SHARE The computation of the basic and diluted weighted average shares outstanding and the basic and diluted earnings(loss) per share for the three and six months ended June 30, 2023 and 2022 consisted of the following: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net income (loss) $ (181,088 ) $ 78,125 $ (328,927 ) $ 284,630 Basic weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Basic earnings (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Effect on dilutive stock awards - 750,000 - 750,000 Diluted weighted average shares outstanding 85,214,086 85,739,086 85,214,086 85,739,086 Diluted earnings (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 For the three and six months ended June 30, 2023,there were 450,000 common share equivalents excluded from the diluted earnings per share calculation as their effect is anti-dilutive.

Disaggregation of Revenues (Tab

Disaggregation of Revenues (Tables)	6 Months Ended
	Jun. 30, 2023
Disaggregation of Revenues [Abstract]
Schedule of Revenues	The Company’s revenues for the three months ended June 30, 2023 and 2022 are disaggregated as follows Three Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 10,508 $ - $ 10,508 OEM and other 81,155 32,721 113,876 Total Revenues $ 91,663 $ 32,721 $ 124,384 Three Months Ended June 30, 2022 United States International Total Revenues Freezers and chillers $ 309,704 $ - $ 309,704 OEM and other 195,604 50,307 245,911 Total Revenues $ 505,308 $ 50,307 $ 555,615 Six Months Ended June 30, 2023 United States International Total Revenues Freezers and chillers $ 55,758 $ - $ 55,758 OEM and other 209,035 100,718 309,753 Total Revenues $ 264,793 $ 100,718 $ 365,511 Six Months Ended June 30, 2022 United States International Total Revenues Freezers and chillers $ 658,162 $ 153,236 $ 811,398 OEM and other 368,047 129,746 497,793 Total Revenues $ 1,026,209 $ 282,982 $ 1,309,191

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jun. 30, 2023
Inventories [Abstract]
Schedule of Inventories	Inventories at June 30, 2023 and December 31, 2022 consisted of the following June 30, December 31, Finished goods $ 365,842 $ 376,334 Raw materials 617,288 527,062 Total inventories 983,130 903,396 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 877,086 $ 797,352

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Schedule of Consolidated Balance Sheet	The following was included in our condensed consolidated balance sheets at June 30, 2023 and December 31, 2022 June 30, December 31, Operating lease right-of-use assets $ 25,008 $ 54,265 Lease liabilities, current portion 26,760 57,393 Lease liabilities, long-term - - Total operating lease liabilities $ 26,760 $ 57,393 Weighted-average remaining lease term (months) 5 11 Weighted average discount rate 5.25% 5.25%
Schedule of Lease Expense	Total lease expense for the three and six months ended June 30, 2023 and 2022 is as follows Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Operating lease expense $ 15,216 $ 15,216 $ 30,432 $ 30,432 Variable lease expense 7,202 1,395 11,639 3,788 Total lease expense $ 22,418 $ 16,611 $ 42,071 $ 34,220
Schedule of Maturities of Operating Lease Liabilities	As of June 30, 2023, maturities of operating lease liabilities were as follows Year Ending December 31, Amount 2023 – remaining $ 27,112 Less: imputed interest (352 ) Total operating lease liabilities $ 26,760

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Stockholders' Equity Note [Abstract]
Schedule of Changes in Restricted Stock Awards Outstanding	Below is a table summarizing the changes in restricted stock awards outstanding during the six months ended June 30, 2023 Restricted Stock Awards Weighted- Outstanding at December 31, 2022 450,000 $ 0.11 Granted - - Vested - - Forfeited - - Outstanding at June 30, 2023 450,000 $ 0.11

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings (Loss) Per Share [Abstract]
Schedule of weighted average shares outstanding and the basic and diluted earnings per share	The computation of the basic and diluted weighted average shares outstanding and the basic and diluted earnings(loss) per share for the three and six months ended June 30, 2023 and 2022 consisted of the following Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net income (loss) $ (181,088 ) $ 78,125 $ (328,927 ) $ 284,630 Basic weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Basic earnings (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00 Weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Effect on dilutive stock awards - 750,000 - 750,000 Diluted weighted average shares outstanding 85,214,086 85,739,086 85,214,086 85,739,086 Diluted earnings (loss) per share $ (0.00 ) $ 0.00 $ (0.00 ) $ 0.00

Disaggregation of Revenues (Det

Disaggregation of Revenues (Details) - Schedule of Revenues - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Freezers and chillers	$ 10,508	$ 309,704	$ 55,758	$ 811,398
OEM and other	113,876	245,911	309,753	497,793
Total Revenues	124,384	555,615	365,511	1,309,191
United States [Member]
Revenues
Freezers and chillers	10,508	309,704	55,758	658,162
OEM and other	81,155	195,604	209,035	368,047
Total Revenues	91,663	505,308	264,793	1,026,209
International [Member]
Revenues
Freezers and chillers				153,236
OEM and other	32,721	50,307	100,718	129,746
Total Revenues	$ 32,721	$ 50,307	$ 100,718	$ 282,982

Inventories (Details) - Schedul

Inventories (Details) - Schedule of Inventories - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Schedule of inventories [Abstract]
Finished goods	$ 365,842	$ 376,334
Raw materials	617,288	527,062
Total inventories	983,130	903,396
Less reserve for obsolescence	(106,044)	(106,044)
Total inventories, net	$ 877,086	$ 797,352

Leases (Details) - Schedule of

Leases (Details) - Schedule of Consolidated Balance Sheet - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Schedule of Condensed Consolidated Balance Sheet [Abstract]
Operating lease right-of-use assets	$ 25,008	$ 54,265
Lease liabilities, current portion	26,760	57,393
Lease liabilities, long-term
Total operating lease liabilities	$ 26,760	$ 57,393
Weighted-average remaining lease term (months)	5 months	11 months
Weighted average discount rate	5.25%	5.25%

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of Lease Expense - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule of Lease Expense [Abstract]
Operating lease expense	$ 15,216	$ 15,216	$ 30,432	$ 30,432
Variable lease expense	7,202	1,395	11,639	3,788
Total lease expense	$ 22,418	$ 16,611	$ 42,071	$ 34,220

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of Maturities of Operating Lease Liabilities - Operating Lease Liabilities [Member]	Jun. 30, 2023 USD ($)
Schedule of Maturities of Operating Lease Liabilities [Abstract]
2023 – remaining	$ 27,112
Less: imputed interest	(352)
Total operating lease liabilities	$ 26,760

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Common stock, shares authorized	100,000,000		100,000,000		100,000,000
Common stock, shares issued	85,214,086		85,214,086		85,214,086
Common stock, shares outstanding	85,214,086		85,214,086		85,214,086
Stock based compensation expense	$ 6,875	$ 906	$ 13,750	$ 13,750
Unrecognized stock-based compensation expense	$ 41,250		$ 41,250
Unrecognized stock-based compensation expense expected to be recognized over period			1 year 6 months

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of Changes in Restricted Stock Awards Outstanding	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Schedule of Changes in Restricted Stock Awards Outstanding [Abstract]
Restricted Stock Awards Outstanding, Beginning | shares	450,000
Weighted-Average Exercise Price Outstanding, Beginning | $ / shares	$ 0.11
Restricted Stock Awards Outstanding, Granted | shares
Weighted-Average Exercise Price Outstanding, Granted | $ / shares
Restricted Stock Awards, Vested | shares
Weighted-Average Exercise Price, Vested | $ / shares
Restricted Stock Awards, Forfeited | shares
Weighted-Average Exercise Price Outstanding, Forfeited | $ / shares
Restricted Stock Awards Outstanding, Ending | shares	450,000
Weighted-Average Exercise Price Outstanding, Ending | $ / shares	$ 0.11

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Earnings (Loss) Per Share [Abstract]
Common share equivalents	450,000	450,000

Earnings (Loss) Per Share (De_2

Earnings (Loss) Per Share (Details) - Schedule of Weighted Average Shares Outstanding and the Basic and Diluted Earnings Per Share - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule of Weighted Average Shares Outstanding and the Basic and Diluted Earnings Per Share [Abstract]
Net income (loss) (in Dollars)	$ (181,088)	$ 78,125	$ (328,927)	$ 284,630
Basic weighted average shares outstanding	85,214,086	84,989,086	85,214,086	84,989,086
Basic earnings (loss) per share (in Dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding	85,214,086	84,989,086	85,214,086	84,989,086
Effect on dilutive stock awards (in Dollars)		$ 750,000		$ 750,000
Diluted weighted average shares outstanding	85,214,086	85,739,086	85,214,086	85,739,086
Diluted earnings (loss) per share (in Dollars per share)	$ 0	$ 0	$ 0	$ 0